CK-NAC LIQUID, 50 mL

    990524



    To access the documentation you must be registered

    Register


    Conformité européenne In vitro diagnostic product

    For in vitro determination of Creatine Kinase in serum or plasma.

    State Líiquid 
    Storage temp. +2 / +8 ºC
    Technique IFCC method

    Documentation

    Only for registered users. Register here
    Current batch :

      Download
      Download
      Download
    Previous batches :

      Download

    PRINCIPLE

    Creatine kinase (CK) releases creatine from phosphocreatine with the aid of ADP that is transformed in ATP. The glucose of reaction media reacts with ATP by the action of hexokinase, forming glucose-6-phosphate. This degrades to 6-phosphogluconate in the presence of glucose-6-phosphate dehydrogenase and NADP+. The reaction reduces the NADP+ to NADH and there is an Abs change.When the reaction conditions are optimum, the ΔAbs/min is directly related to the CK activity of the sample.

    DIAGNOSTIC USE

    Mostly, the increase of CK values is related to diseases of skeletal muscle or the heart. Values higher than usual are observed after trauma, surgery, myopathic disorders, myocardial infarction, prolonged hypothermia or hypothyroidism. Also, elevated values are described in cases of Reye syndrome or Duchenne disease.

    Results lower than the reference values may reflect a sedentary lifestyle or the presence of low muscle mass.

    Single test result can not be used to make a clinical diagnosis. It should integrate clinical and laboratory data.